UTERINE FIBROID TREATMENT DEVICES MARKET ANALYSIS

Uterine Fibroid Treatment Devices Market by Technology Type (Surgical Technique (Hysterectomy and Myomectomy) Laparoscopic techniques (Laparoscopic Myomectomy and Myolysis) Ablation Techniques (Microwave Ablation, Cryoablation, and Ultrasound Ablation (High Intensity Focused Ultrasound (HIFU) and MRI-guided Focused Ultrasound (MRgFUS)) Other Ablation Techniques) Embolization Techniques) by Mode of Treatment (Invasive Treatment, Minimally Invasive Treatment, and Non-Invasive Treatment) By End User (Hospitals, Clinics, and Ambulatory Surgical Center)- Size, Share, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Sep 2024
Code : CMI2047
Formats :
Excel and PDF
Industry : Medical Devices

Regional Analysis

Uterine Fibroid Treatment Devices Market – Regional Analysis

On the basis of regional segmentation, the global Uterine Fibroid Treatment Devices Market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is expected to dominate the market due to increased prevalence of uterine fibroid in women present in the U.S. According to Center for Disease Control and Prevention (CDC) in the U.S. an estimated 9,727 women died from uterine cancer in 2014, which is propelling demand for uterine fibroid treatment in the U.S.

Asia Pacific region is also expected to witness significant growth in uterine fibroid treatment in near future due to growing healthcare awareness within the population in economies such as China and India. Whereas, advancement in uterine fibroid treatment such as, minimal invasive treatment, embolization procedure, myomectomy and hysterectomy are also expected to support growth of the Uterine Fibroid Treatment Devices Market worldwide in near future. For instance, MyoSure by Hologicreceived CE Mark in Europe, MyoSure system is a minimally invasive hysteroscopic treatment option that is quick and convenient removal of tissue, which include range of fibroids and polys.

By Region